Salix Pharmaceuticals Book Value:
560.50M for Dec. 31, 2012Salix Pharmaceuticals Historical Book Value Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 560.50M |
| Sept. 30, 2012 | 532.60M |
| June 30, 2012 | 504.42M |
| March 31, 2012 | 475.33M |
| Dec. 31, 2011 | 549.64M |
| Sept. 30, 2011 | 480.43M |
| June 30, 2011 | 438.92M |
| March 31, 2011 | 407.84M |
| Dec. 31, 2010 | 401.92M |
| Sept. 30, 2010 | 370.06M |
| June 30, 2010 | 369.43M |
| March 31, 2010 | 353.49M |
| Dec. 31, 2009 | 370.02M |
| Sept. 30, 2009 | 237.42M |
| June 30, 2009 | 239.84M |
| March 31, 2009 | 253.16M |
| Dec. 31, 2008 | 265.40M |
| Sept. 30, 2008 | 259.60M |
| June 30, 2008 | 263.71M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Book Value of Equity
YCharts' book value of equity is the equivalent of total assets less total liabilities and preferred equity.
The book value of equity represents the equity of shareholders (from a balance sheet perspective) less the preferred stock.
Learn More
SLXP Book Value Benchmarks
| Companies | |
|---|---|
| Catalyst Pharmaceutical Partners | 14.62M |
| Valeant Pharmaceuticals International | 3.587B |
| Auxilium Pharmaceuticals | 231.96M |
SLXP Book Value Rankings
| Overall |
77th percentile 1811 of 8002 |
| Sector |
81st percentile 118 of 650 in Healthcare |
| Industry |
81st percentile 12 of 65 in Drug Manufacturers - Specialty & Generic |
SLXP Book Value Range, Past 5 Years
| Minimum | 237.41M | Sep 2009 |
| Maximum | 560.50M | Dec 2012 |
| Average | 385.99M |
SLXP News
Salix Pharmaceuticals Outlines Data Presentations at Digestive Disease Week 2013
Business Wire May 17
Business Wire May 17